City
Epaper

Pinworm medication may treat aggressive skin cancer: Researchers

By IANS | Updated: April 20, 2025 11:22 IST

New York, April 20 A team of US scientists has found that a common pinworm medication may stop ...

Open in App

New York, April 20 A team of US scientists has found that a common pinworm medication may stop and reverse cancer growth in Merkel cell carcinoma, an aggressive form of skin cancer.

The research led by University of Arizona Cancer Center and published in the Journal of Clinical Investigation, found that in laboratory models of Merkel cell carcinoma, pyrvinium pamoate inhibited cancer cell growth and reversed the cancer’s neuroendocrine features.

In mouse models of Merkel cell carcinoma, pyrvinium pamoate reduced tumour growth.

Merkel cell carcinoma is a rare but fast-growing neuroendocrine cancer that is three to five times more likely than melanoma to be deadly. Response rates to current therapies – surgery, radiation and immunotherapy – are limited, resulting in a need for effective and broadly applicable therapeutics.

“Merkel cell carcinoma is increasing in incidence. Even though it’s a rare cancer type, it mimics a lot of properties that other cancers have,” said senior author Megha Padi, assistant professor at the university.

Pyrvinium pamoate, a medication approved by the Food and Drug Administration in 1955 to treat pinworms, has been shown to have antitumour potential in several different cancers, including breast, colorectal, pancreatic and bladder cancers. This is the first time it has been studied in models of Merkel cell carcinoma.

Padi and the research team found that in laboratory models of Merkel cell carcinoma, pyrvinium pamoate inhibited cancer cell growth and reversed the cancer’s neuroendocrine features. In mouse models of Merkel cell carcinoma, pyrvinium pamoate reduced tumor growth.

“This is a hypothesis, but some people think the reason an antiparasitic agent could be effective against cancers is because tumours are a little bit like parasites in our body,” Padi said. “Parasites and tumours must develop ways to use scarce resources in their host to feed themselves and allow for unlimited multiplication. If the pathways that they have hijacked to feed themselves are the same, then you get lucky, and you have a tumour type that could be amenable to killing by these antiparasitic drugs.”

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

TechnologyNew ICMR study unravels breast cancer risk factors among Indian women

NationalNagpur Water Tank Collapse: Maharashtra Government Assures Rs 5 Lakh Aid, Nitish Kumar Announces Rs 2 Lakh Ex Gratia; Company to Pay Rs 30 Lakh to Deceased Workers’ Families

HealthAmid rising air pollution, Delhi Minister outlines govt’s preparedness to tackle crisis

HealthNew ICMR study unravels breast cancer risk factors among Indian women

InternationalUN marks second World Meditation Day with focus on inner peace, global harmony

Technology Realted Stories

TechnologySeveral key bridges exemplify scale and vision of India’s infrastructure

TechnologyGoogle warns employees against travel outside US due to stamping delays of up to 12 months

TechnologyHPV vaccine can help prevent precancerous lesions in girls, women

TechnologyTicker‑mapping error likely behind sudden spike in Infosys ADRs: Report

TechnologyCommon air pollutants may impair mood, memory in adolescents: Study